Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Correcting Rare Blood Disorders Using Coagulation Factors Produced In Vivo By Shielded Living Therapeutics TM Products

Guillaume Carmona, PhD, Lauren Barney, PhD, Jared Sewell, PhD, Ryan Newman, Christine Carroll, Michael Beauregard, Janet Huang, MSc, Richard W Heidebrecht, Jr., PhD, Deya Corzo, MD, David Moller, MD, Devyn Smith, PhD, David Peritt, PhD, Rogerio Vivaldi, MD MBA

Blood (2019) 134 (Supplement_1): 2065.

https://doi.org/10.1182/blood-2019-127050

Published: 2019

Journal Articles

Development of Novel Second Generation DC/Tumor Fusion Vaccine in Lymphoma

Shira Orr, PhD, Marzia Capelletti, PhD MBBS, Haider Ghiasuddin, Dina Stroopinsky, PhD, Jessica Liegel, MD, Myrna Nahas, MD, Matthew Weinstock, MD, Adam Morin, Robin M. Joyce, MD, Salvia Jain, MD, Jon E. Arnason, MD, Maryam Rahimian, MD, Lina Bisharat, Shufen Meng, MD, Donald Kufe, MD, Jacalyn Rosenblatt, MD, David E. Avigan, MD

Blood (2019) 134 (Supplement_1): 392.

https://doi.org/10.1182/blood-2019-124768

Published: 2019

Journal Articles

Harnessing Microfluidic Single Cell (MF-SC) and 3D "Organ-on-Chip" Assay Technologies for the Investigation of Immunotherapy and Study of Tumor Microenvironment (TME) in Antibody-Resistant Non-Hodgkin Lymphoma (NHL)

Ravi Dashnamoorthy, PhD, Saheli Sarkar, PhD, Pooja Sabachandani, MS, Sneha Purvey, MD, Afshin Beheshti, PhD, Tali Konry, PhD, Andrew M Evens, DO,MSc

Blood (2017) 130 (Supplement 1): 1473.

https://doi.org/10.1182/blood.V130.Suppl_1.1473.1473

Published: 2017

Journal Articles

Development of Foam-Based 3-Dimensional Culture to Investigate Drug Sensitivity in Primary Leukaemia Cells

Mahroo Karimpoor, PhD, Eva Yebra-Fernandez, MD, Maryam Parhizkar, PhD, Mine Orlu, Duncan Craig, PhD, Mohan Edirisinghe, PhD, Jamshid S Khorashad, MD PhD

Blood (2017) 130 (Supplement 1): 3824.

https://doi.org/10.1182/blood.V130.Suppl_1.3824.3824

Published: 2017

Journal Articles

A Novel Phase-Change Hydrogel Substrate for T Cell Activation Promotes Increased Expansion of CD8+ Cells Expressing Central Memory and Naive Phenotype Markers

Nithya J Jesuraj, PhD, Julie M Cole, BA, BS, Felipe Bedoya, PhD, Steven B Wells, BS, Guokui Qin, PhD, Sean Kevlahan, PhD, Marcela V. Maus, MD PhD, Andrew J Ball, PhD

Blood (2016) 128 (22): 3368.

https://doi.org/10.1182/blood.V128.22.3368.3368

Published: 2016

Journal Articles

Nanoparticle-Encapsulated Allogeneic T Cells Mitigate Graft-Versus-Host Disease but Retain Graft-Versus-Leukemia Activity

Lingling Zhang, PhDMD, Shuting Zhao, Steven M. Devine, MD, Xiaoming He, PhD, Jianhua Yu, PhD

Blood (2014) 124 (21): 3820.

https://doi.org/10.1182/blood.V124.21.3820.3820

Published: 2014

Journal Articles

Dose-Response Titration In a Bone Marrow Niche Model Reveals AKT As a Target That Modulates Sensitivity Of Myeloid Leukemia To Extracellular Matrix Mechanics: Implications In Drug Resistance

Jae-Won Shin, Ph.D., David J. Mooney, Ph.D.

Blood (2013) 122 (21): 1292.

https://doi.org/10.1182/blood.V122.21.1292.1292

Published: 2013

Journal Articles

Structural and Functional Characterization of Fucoidan and Its Procoagulant Effect in An Ex Vivo Model of Factor VIII-Inhibited Guinea Pigs

Michael Dockal, PhD, Werner Hoellriegl, Zhenqing Zhang, Susanne Till, PhD, Sabine Knappe, PhD, Michael Palige, PhD, Alexandra Schiviz, Hartmut J. Ehrlich, MD, Christina Szabo, Eva-Maria Muchitsch, Friedrich Scheiflinger, PhD

Blood (2011) 118 (21): 2262.

https://doi.org/10.1182/blood.V118.21.2262.2262

Published: 2011

Journal Articles

Endostatin Inhibits VEGF-Induced Lung Edema by Reducing Vascular Permeability.

Gunter Schuch, MD, Suleyman Erguen, MD, Shay Soker, PhD, Dieter K. Hossfeld, MD, Walter Fiedler, MD

Blood (2004) 104 (11): 2614.

https://doi.org/10.1182/blood.V104.11.2614.2614

Published: 2004

Journal Articles

Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2

Blood (2003) 102 (5): 1815–1823.

https://doi.org/10.1182/blood-2002-12-3772

Published: 2003

NARROW

Correcting Rare Blood Disorders Using Coagulation Factors Produced In Vivo By Shielded Living Therapeutics TM Products

Development of Novel Second Generation DC/Tumor Fusion Vaccine in Lymphoma

Harnessing Microfluidic Single Cell (MF-SC) and 3D "Organ-on-Chip" Assay Technologies for the Investigation of Immunotherapy and Study of Tumor Microenvironment (TME) in Antibody-Resistant Non-Hodgkin Lymphoma (NHL)

Development of Foam-Based 3-Dimensional Culture to Investigate Drug Sensitivity in Primary Leukaemia Cells

A Novel Phase-Change Hydrogel Substrate for T Cell Activation Promotes Increased Expansion of CD8+ Cells Expressing Central Memory and Naive Phenotype Markers

Nanoparticle-Encapsulated Allogeneic T Cells Mitigate Graft-Versus-Host Disease but Retain Graft-Versus-Leukemia Activity

Dose-Response Titration In a Bone Marrow Niche Model Reveals AKT As a Target That Modulates Sensitivity Of Myeloid Leukemia To Extracellular Matrix Mechanics: Implications In Drug Resistance

Structural and Functional Characterization of Fucoidan and Its Procoagulant Effect in An Ex Vivo Model of Factor VIII-Inhibited Guinea Pigs

Endostatin Inhibits VEGF-Induced Lung Edema by Reducing Vascular Permeability.

Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only